drugset
drugset / Trial / NCT04090086

A Study to Assess Interaction Between JNJ-64417184 and JNJ-53718678 After Single and Multiple Dosing in Healthy Participants

NCT04090086 ↗

Phase 1 Completed 16 enrolled Janssen Research & Development, LLC
RandomizedCrossoverOpen-labelOther

Summary

The purpose of this study is to evaluate the effect of single and multiple dose (once daily for 7 days) oral JNJ-64417184 and JNJ-53718678 on the pharmacokinetic (PK) of single and multiple-dose (once daily for 7 days) oral JNJ 53718678 and JNJ-64417184, respectively when coadministered to healthy adult participants under fed conditions.

Timeline

Start
2019-09-16
Primary completion
2019-12-10
Completion
2019-12-10

Drugs

EvaluationDrugModalityDoseRoute
Subject JNJ-64417184 Unknown — Oral
Subject Rilematovir Other / unclassified — Oral

Indications

No indication recorded.